TSXV:BTI.H - Post by User
Comment by
prophetoffactzon Dec 30, 2022 4:21pm
110 Views
Post# 35197708
RE:Midatech at $1.0475
RE:Midatech at $1.0475With US$20 million cash plus any cash from licensing deals and/or strategic partnerships Biodexa has enough of a cash runway to reach key hard catalysts. We need to start pricing in these catalysts over the next 18 months given the cash runway. What's a 10-15-20% chance at $12 billion given the market value of the lead clinical/near clinical programs? Additionally, what's the value of Q-Sphera/xB3 validated by the world's largest healthcare company and Chiesi, etc.? As the CEO of Biodexa stated he defies anyone to find a greater opportunity set in biotech for a company this size!
This is a SALTARELLI!
Armistice and Ladenberg Thalmann are on board!
Boomskid wrote: That means that V.BTI's value, as caculated by the terms of the deal, is now about 5.2¢
If U.MTP keeps that up it will be worth it to buy Bioasis instead of MTP.
Hard to imagine 6¢ these days.
jd